Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals
- PMID: 24439479
- PMCID: PMC4022140
- DOI: 10.1016/j.neurobiolaging.2013.12.030
Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals
Abstract
Previous studies have suggested a link between sleep disordered breathing (SDB) and dementia risk. In the present study, we analyzed the relationship between SDB severity, cerebrospinal fluid (CSF) Alzheimer's disease-biomarkers, and the ApoE alleles. A total of 95 cognitively normal elderly participants were analyzed for SDB severity, CSF measures of phosphorylated-tau (p-tau), total-tau (t-tau), and amyloid beta 42 (Aβ-42), as well as ApoE allele status. In ApoE3+ subjects, significant differences were found between sleep groups for p-tau (F[df2] = 4.3, p = 0.017), and t-tau (F[df2] = 3.3, p = 0.043). Additionally, among ApoE3+ subjects, the apnea and/or hypopnea with 4% O2-desaturation index was positively correlated with p-tau (r = 0.30, p = 0.023), t-tau (r = 0.31, p = 0.021), and Aβ-42 (r = 0.31, p = 0.021). In ApoE2+ subjects, the apnea and/or hypopnea with 4% O2-desaturation index was correlated with lower levels of CSF Aβ-42 (r = -0.71, p = 0.004), similarly to ApoE4+ subjects where there was also a trend toward lower CSF Aβ-42 levels. Our observations suggest that there is an association between SDB and CSF Alzheimer's disease-biomarkers in cognitively normal elderly individuals. Existing therapies for SDB such as continuous positive airway pressure could delay the onset to mild cognitive impairment or dementia in normal elderly individuals.
Keywords: Alzheimer's disease; Amyloid beta 42; ApoE; Biomarkers; CSF; Cerebral amyloid angiopathy; Elderly; Sleep-disordered breathing; p-tau.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367
-
Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.Sleep. 2016 Jun 1;39(6):1253-60. doi: 10.5665/sleep.5846. Sleep. 2016. PMID: 26951396 Free PMC article.
-
Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.J Alzheimers Dis. 2016 Jul 29;54(1):157-68. doi: 10.3233/JAD-160176. J Alzheimers Dis. 2016. PMID: 27472875
-
Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6. Methods. 2012. PMID: 22503777 Review.
-
Association between obstructive sleep apnea and Alzheimer's disease-related blood and cerebrospinal fluid biomarkers: A meta-analysis.J Clin Neurosci. 2022 Aug;102:87-94. doi: 10.1016/j.jocn.2022.06.004. Epub 2022 Jun 23. J Clin Neurosci. 2022. PMID: 35753156 Review.
Cited by
-
Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults.Neurobiol Aging. 2015 Sep;36(9):2568-76. doi: 10.1016/j.neurobiolaging.2015.05.004. Epub 2015 May 14. Neurobiol Aging. 2015. PMID: 26059712 Free PMC article.
-
Prevalence of obstructive sleep apnea in Alzheimer's disease patients.J Neurol. 2020 Apr;267(4):1012-1022. doi: 10.1007/s00415-019-09668-4. Epub 2019 Dec 12. J Neurol. 2020. PMID: 31832828
-
The prevalence of obstructive sleep apnea in mild cognitive impairment: a systematic review.BMC Neurol. 2019 Aug 15;19(1):195. doi: 10.1186/s12883-019-1422-3. BMC Neurol. 2019. PMID: 31416438 Free PMC article.
-
Absence of Relationship Between Self-Reported Sleep Measures and Amyloid Load in Elderly Subjects.Front Neurol. 2019 Sep 13;10:989. doi: 10.3389/fneur.2019.00989. eCollection 2019. Front Neurol. 2019. PMID: 31572295 Free PMC article.
-
A New Perspective on the Treatment of Alzheimer's Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help?Oxid Med Cell Longev. 2022 Jan 12;2022:6168199. doi: 10.1155/2022/6168199. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35069976 Free PMC article. Review.
References
-
- Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, Lampe J, Kahn SE, Craft S. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol. 2011;68:743–52. - PMC - PubMed
-
- Blennow K, Zetterberg H. The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease. Med Clin North Am. 2013;97:369–76. - PubMed
-
- Braak H, Braak E. Staging of alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging. 1995;16:271–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous